- 0208 903 4819
- Weekday Hours: 10AM - 5PM
Mounjaro® has been authorised for weight management use in the UK. The approval for weight management also comes from the US Food and Drugs Administration (FDA) as well as the Medicines and Healthcare products Regulatory Agency (MHRA). Mounjaro® (tirzepatide) is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus. It is a dual-acting incretin mimetic that works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). GIP and GLP-1 help to control blood sugar levels by increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.
Mounjaro® works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help to control blood sugar levels by increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.
Mounjaro® works by mimicking the effects of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These hormones help to control blood sugar levels by increasing insulin secretion, slowing gastric emptying, and suppressing glucagon secretion.
Increasing insulin secretion: Mounjaro® stimulates the release of insulin from the pancreas, which helps to lower blood sugar levels.
Slowing gastric emptying: Mounjaro® slows down the movement of food from the stomach into the small intestine, which helps you feel full for longer and eat less.
Suppressing glucagon secretion: Suppressing glucagon secretion: Mounjaro® reduces the release of glucagon from the pancreas, which helps to prevent the liver from releasing too much sugar into the bloodstream.
Mounjaro® has been shown to be effective in promoting weight loss in adults with type 2 diabetes and obesity. In one study, patients who took Mounjaro® for 84 weeks had an average weight loss of 10.2kg, compared with a weight loss of 1.2kg in patients who took a placebo. Mounjaro® was also shown to be more effective than semaglutide for weight loss.
In a research involving about 2500 patients with Mounjaro® (tirzepatide), patients on:
Mounjaro® has been shown to be effective in promoting weight loss in adults with type 2 diabetes and obesity. In one study, patients who took Mounjaro® for 84 weeks had an average weight loss of 10.2kg, compared with a weight loss of 1.2kg in patients who took a placebo. Mounjaro® was also shown to be more effective than semaglutide for weight loss.
In a research involving about 2500 patients with Mounjaro® (tirzepatide), patients on:
Always use this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.
Do not change your dose unless your doctor has told you to.
Always use this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.
Do not change your dose unless your doctor has told you to.
Each pen contains one dose of Mounjaro either:
You can use your pen at any time of the day, with or without meals. You should use it on the same day each week if you can. To help you remember, when to use Mounjaro®, you may wish to tick the day of the week when you inject your first dose on the box that your pen comes in, or mark it on a calendar.
If necessary, you can change the day of your weekly Mounjaro® injection, as long as it has been at least 3 days since your last injection. After selecting a new dosing day, continue with once-a-week dosing on that new day.
Each pen contains one dose of Mounjaro either:
You can use your pen at any time of the day, with or without meals. You should use it on the same day each week if you can. To help you remember, when to use Mounjaro®, you may wish to tick the day of the week when you inject your first dose on the box that your pen comes in, or mark it on a calendar.
If necessary, you can change the day of your weekly Mounjaro® injection, as long as it has been at least 3 days since your last injection. After selecting a new dosing day, continue with once-a-week dosing on that new day.
Mounjaro® (tirzepatide) is a prescription medication that is used to treat adults with type 2 diabetes. It has also been licensed to be used for weight management and obesity.
To qualify for Mounjaro® for type 2 diabetes, you must:
If unsure if Mounjaro® is suitable for you, always consult with a doctor to make sure you are fine to take the medicine.
To qualify for Mounjaro® for weight management, you must:
If unsure if Mounjaro® is suitable for you, always consult with a doctor to make sure you are fine to take the medicine.
Mounjaro® (tirzepatide) is a prescription medication that is used to treat adults with type 2 diabetes. It has also been licensed to be used for weight management and obesity.
To qualify for Mounjaro® for type 2 diabetes, you must:
If unsure if Mounjaro® is suitable for you, always consult with a doctor to make sure you are fine to take the medicine.
To qualify for Mounjaro® for weight management, you must:
If unsure if Mounjaro® is suitable for you, always consult with a doctor to make sure you are fine to take the medicine.
There are several reasons why you might not be able to take Mounjaro® (tirzepatide). Some reasons why you may not be approved for Mounjaro® could be related to your current medications, if you are pregnant or breastfeeding or your kidney function.
It is very important to undergo a medical assessment to make sure you will be 100% safe when taking Mounjaro so that you don’t suffer from any serious side effects or cause any damage to your health.
Like all medications, there are some potential side effects from this medication. These include the following:
Please always read the Patient Information Leaflet provided to learn about the potential side effects. Email [email protected] for more information.
Like all medications, there are some potential side effects from this medication. These include the following:
Please always read the Patient Information Leaflet provided to learn about the potential side effects. Email [email protected] for more information.
Read our articles on Mounjaro & Wegovy if you would like to learn more about the benefits, the research and case studies.
All consultations and prescriptions are carried out by GMC registered medical practitioners.
All dispensing and shipping of medicines are completed by a UK licensed, GPhC registered Pharmacy no: 9011284.
CloudRx is our partner pharmacy and prescribing service.
*Disclaimer: Results may vary from person to person depending on individual engagement and commitment to the programme.
The content of this website is provided for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice. Do not use the information on this website for diagnosing or treating any medical or health related condition. If you have or suspect you have a medical problem, promptly contact your healthcare provider.
© 2023 The London Obesity Clinic
